UCT Genetics Postdoctoral Research Fellowship for Sub-Saharan Africans in Africa

The
Genetics Postdoctoral Research Fellowship is now available at The University of
Cape Town in South Africa for the year 2019. Students from Sub-Saharan Africa
are eligible to apply for this fellowship.
The
HIGENES Africa project aims to use Whole genome sequencing (WES),
bio-informatic analysis and functional studies to study the largest sample of
sub-Saharan Africans from Cameroon, Mali, Ghana, Sudan, Rwanda and South Africa
with prelingual autosomal recessive non-syndromic hearing impairment (ARNSHI),
to identify novel and relevant NSHI genes in African populations.

The
University of Cape Town is a public research university located in Cape Town in
the Western Cape province of South Africa. UCT was founded in 1829 as the South
African College making it the oldest higher education institute in South
Africa.
Scholarship Description
  • Applications
    Deadline: 
    November 26, 2018
  • Course
    Level:
    Fellowships are available to
    pursue Postdoctoral programme.
  • Study
    Subject:
    The Division of Human Genetics
    invites highly motivated individuals to apply for a Genetics Postdoctoral
    Research Fellowship to be part of a multidisciplinary team of experts as
    part of the Hearing Impairment Genetics Study in Africa (HIGeneS Africa)
    project under the directorship of Prof Ambroise Wonkam.
  • Scholarship Award:
    The fellowship is valued at R300 000 per annum. The fellowship may be
    renewed for a second year depending on satisfactory progress and mutual
    agreement.
  • Nationality:
    Students from Sub-Saharan Africa
    are eligible to apply for this fellowship.
  • Number
    of Scholarships:
    Numbers not given
  • Scholarship can
    be taken in
    Africa
Eligibility for the Scholarship
Eligible
Countries: 
Students from Sub-Saharan Africa
(Angola, Benin, Botswana, Burkina
Faso, Burundi, Cameroon, Cape Verde, Central African
Republic, Chad, Comoros, Congo (Brazzaville), Congo (Democratic
Republic), Ivory Coast, Djibouti, Equatorial Guinea, Eritrea,
Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Kenya,
Lesotho, Liberia, Madagascar, Malawi, Mali, Mauritania, Mauritius,
Mozambique, Namibia, Niger, Nigeria, Rwanda, Sao Tome and
Principe, Senegal, Seychelles, Sierra Leone, Somalia, South Africa, South
Sudan, Sudan, Swaziland, Tanzania, Togo, Uganda, Zambia and Zimbabwe) are
eligible to apply.
Entrance
Requirements: Applicants must meet the following criteria:
Applicants
must have:
  • A
    PhD degree (achieved within 2 years of this application) in an area of
    Human Genetics, Molecular/Cell Biology or Bioinformatics.
  • Proficient
    in standard molecular biology techniques (e.g. cloning, site-directed
    mutagenesis, and fragment analysis, DNA and RNA isolation, quantitative
    Real-Time PCR, RNA interference), and immunoblotting), common cell biology
    techniques (e.g. immunofluorescence). Experience in sequence library
    preparation (e.g., using the Illumina NextSeq™ 500)
  • Experience
    in basic statics like R, SPSS and STATA
  • Previous
    experience in LIMS and quality control
The
following would be advantageous:
  • Evidence
    of a publication record
  • Bioinformatics
    skill set needed to process raw FASTQ files
English
Language Requirements: 
Applicants whose
first language is not English are usually required to provide evidence of
proficiency in English at the higher level required by the University.
Application Procedure
How
to Apply: 
Please email applications to Dr Carmen
de Kock (carmen.dekock-at-uct.ac.za)
The
following documents are required:
  • A
    letter of application in which the candidate’s research interests are
    outlined;
  • A
    Curriculum Vitae, including a list of publications;
  • Certified
    copies of all academic transcripts (no certificates); and
  • The
    names and contact details of two academic referees who have
    taught/supervised the applicant.
0 0 votes
Article Rating
Subscribe
Notify of
guest

0 Comments
0
Would love your thoughts, please comment.x
()
x